Trending News
News
News
Illumina Completes Acquisition of GenoLogics
Illumina’s to drive the adoption of sequencing in new markets and improve the genomic workflow.
News
Dow AgroSciences Signs Deal for Rice Genome-Editing Technology in China
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, has entered into a collaboration agreement with the Institute of Crop Sciences of the Chinese Academy of Agricultural Sciences (ICS-CAAS).
News
Taconic Biosciences to Fund Custom Model Development and Breeding
Taconic awards integrated solution as sponsor of rare disease challenge.
News
Resverlogix Presents New Data at the ESC Congress 2015
Company presents new data on RVX-208 "apabetalone" a selective BET inhibitor.
News
PMC to Recognize NIH Director with Leadership in Personalized Medicine Award
Dr. Francis S. Collins to accept award, deliver comments during 11th Annual Personalized Medicine Conference at Harvard Medical School.
News
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
News
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
News
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
News
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Advertisement